The risk of fractures in postmenopausal women with primary hyperparathyroidism

European Journal of Endocrinology

Volumn 155, Issue 3, 2006, Pages 415-420

  De Geronimo, Simona ^a   Romagnoli, Elisabetta ^a   Diacinti, Daniele ^a   D'Erasmo, Emilio ^a   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; CALCULATION; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK FRACTURE; FRACTURE; GONAD FUNCTION; HUMAN; LUMBAR SPINE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

AGED; ANTHROPOMETRY; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; POSTMENOPAUSE; RISK ASSESSMENT;

EID: 33749077099     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02225     Document Type: Article

References (29)

1. Khan A & Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. Canadian Medical Association Journal 2000 163 184-187.
2. Cormier C, Souberbielle JC & Kahan A. Primary hyperparathyroidism and osteoporosis in 2004. Joint Bone Spine 2004 71 183-189.
3. Bilezikian JP, Rubin M & Silverberg SJ. Primary hyperparathyroidism: diagnosis, evaluation, and treatment. Current Opinion in Endocrinology and Diabetes 2004 11 345-352.
4. Bilezikian JP, Brandi ML, Rubin M & Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. Journal of Internal Medicine 2005 257 6-17.
5. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL & Bilezikian JP. Skeletal disease in primary hyperparathyroidism. Journal of Bone and Mineral Research 1989 4 283-291.
6. Dempster DW, Parisien M, Silverberg SJ, Liang X-G, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R & Bilezikian JP. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 1562-1566.
7. Rubin MR, Cosman F, Lindsay R & Bilezikian JP. The anabolic effects of parathyroid hormone. Osteoporosis International 2002 13 267-277.
8. Wilson RJ, Sudhaker R, Ellis B, Kleerekoper M & Parlitt MA. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Annals of Internal Medicine 1988 109 959-962.
9. Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E & Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. Journal of Internal Medicine 1993 234 585-593.
10. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M & Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. British Medical Journal 2000 321 598-602.
11. Khosla S, Melton LJ, III, Wermers RA, Crowson CS, O'Fallon WM & Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. Journal of Bone and Mineral Research 1999 14 1700-1707.
12. Vestergaard P & Mosekilde L. Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study. Journal of Internal Medicine 2004 255 108-114.
13. Kenny AM, MacGillivray DC, Pilbeam CC, Crombie HD & Raisz LG. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 1995 118 109-114.
14. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF & Ensrud KE. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996 348 1535-1541.
15. Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I & Johnell O, European Vertebral Osteoporosis Study. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporosis International 2003 14 61-68.
16. Bilezikian JP & Potts JT, Jr. Asymptomatic primary hyperparathyroidism: new issues and new questions-bridging the past with the future. Journal of Bone and Mineral Research 2002 17 N57-N67.
17. Genant HK, Wu CY, van Kuijk C & Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research 1993 8 1137-1148.
18. Genant HK & Jergas M. Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporosis International 2003 14 S43-S55.
19. Duan Y, Parfitt MA & Seeman E. Vertebral bone mass, size, and volumetric density in women with spinal fractures. Journal of Bone and Mineral Research 1999 14 1796-1802.
20. Carnevale V, Manfredi G, Romagnoli E, De Geronimo, S, Paglia F, Pepe J, Scillitani A, D'Erasmo E & Minisola S. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clinical Endocrinology 2004 60 81-86.
21. Bilezikian JP & Silverberg SJ. Asymptomatic primary hyperparathyroidism. New England Journal of Medicine 2004 350 1746-1751.
22. Minisola S, Rosso R, Romagnoli E, Pepe J, De Geronimo S, Dionisi S, Paglia F, Raejentroph N, Aliberti G & Mazzuoli GF. Uneven deficits in vertebral bone density in postmenopausal patients with primary hyperparathyroidism as evaluated by posterior-anterior and lateral dual-energy absorptiometry. Osteoporosis International 2002 13 618-623.
23. Bilezikian JP. Bone strength in primary hyperparathyroidism. Osteoporosis International 2003 14 S113-S117.
24. Parfitt MA. Parathyroid hormone and periosteal bone expansion. Journal of Bone and Mineral Research 2002 17 1741-1743.
25. Chen Q, Kaji H, Iu M-F, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T & Chihara K. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 4655-4658.
26. Kaji H, Yamauchi M, Chihara K & Sugimoto T. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. European Journal of Endocrinology 2005 153 373-378.
27. Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP & Myers SL. Effects of teriparatide (recombinant human parathyroid hormone (1-34)) on cortical bone in postmenopausal women with osteoporosis. Journal of Bone and Mineral Research 2003 18 539-543.
28. Nordenström E, Westerdahl J, Lindergard B, Lindblom P & Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World Journal of Surgery 2002 26 1463-1467.
29. Bischoff-Ferrari HA. Extra-skeletal effects of vitamin D. Current Opinion in Endocrinology and Diabetes 2005 2 464-470.